OPTRELL™ Mapping Catheter with TRUEref™ Technology
Catheter, Intracardiac Mapping, High-Density Array. 510(k) K230253, from Biosense Webster, Inc. (Irvine, CA). Product code MTD, class 2.
As of Nov 20, 2026, K230253 is an FDA 510(k) held by Biosense Webster, Inc., substantially equivalent on Mar 2, 2023 after 30 days, with no recalls tied to it in FDA's recall database.
- Review time: 30 days
- Recalls: 0
The OPTRELL™ Mapping Catheter with TRUEref™ Technology is indicated for multiple electrode electrophysiological mapping of cardiac structures in the heart, i.e., recording or stimulation only. This catheter is intended to obtain electrograms in the atrial and ventricular regions of the heart.
- OPTRELL Mapping Catheter with TRUEref TechnologyK211438 · Biosense Webster, Inc. · Mar 18, 2022
- OptiMap Catheter - 60mm (OPTI-CATH2-60)K261012 · Cortex, Inc. · Apr 23, 2026
- OptiMap Catheter - 50mm (OPTI-CATH2-50)K253205 · Cortex, Inc. · Mar 13, 2026
- Sphere-9Dx Diagnostic Catheter (AFR-00009)K233433 · Medtronic · Aug 7, 2024
- Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™K241372 · Abbott Medical · Jul 9, 2024
- PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster®…K231312 · Biosense Webster, Inc. · Jul 10, 2023
- Ablacath™ Mapping CatheterK223666 · Ablacon, Inc. · Mar 17, 2023
- AcQMap 3D Imaging and Mapping Catheter, Model 900009K210766 · Acutus Medical, Inc. · Jun 21, 2022
- OPTRELL Mapping Catheter with TRUEref TechnologyK211438 · Biosense Webster, Inc. · Mar 18, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 31, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1220
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files